The pathway of public celebration followed by private concern and then public repudiation damages the industry's credibility and ability to achieve positive outcomes.
It is never too late for a considered response - caution
September 13, 2024 Latest NewsBioPharmaComment![](https://e76bb9fd1f54a7a912eb-40f6ec802f763655ee14c32dfe77820e.ssl.cf4.rackcdn.com/c7a0990f36d0eddffc4ff2520dd81b9a.png)
Latest Video
New Stories
-
Wesfarmers Health announces plan to build new fulfilment centre in Cairns
September 17, 2024 - - Latest News -
Medicines Australia launches next phase of campaign in PM's electorate
September 17, 2024 - - Latest News -
The HTA Review report - 'Red Flag' number three of five
September 17, 2024 - - Latest News -
Immutep says its candidate in combination with Keytruda delivered positive efficacy and safety profile
September 16, 2024 - - Latest News -
Medicines Australia responds to questions on the HTA Review
September 16, 2024 - - Latest News -
The HTA Review report - 'Red Flag' number two of five
September 16, 2024 - - Latest News -
Australian company Kazia executes licensing agreement with QIMR Berghofer
September 16, 2024 - - Latest News